Elizabeth G Nabel
CIK 1619929 · Lihat di SEC EDGAR ↗
Orang Dalam
Pengajuan SEC Pertama: 16 Juni 2021 · Terbaru: 12 Juni 2026
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
Orang Dalam di
Transaksi orang dalam
0 beli (P)
0 jual (S)
Bersih:
$0
+ 51 transaksi non-pasar di bawah
12 bulan terakhir, berdasarkan transaksi yang ditunjukkan di bawah ini
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
51 pengajuan lain disembunyikan
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 15 Juli 2020 | MRNA | S 10b5-1 | 73.975 | $87,84 | $6.497.964 | 0 Langsung | -100,00% | Dilepas | 62,9% (harga per 2026-08-21) |
| 12 Mei 2020 | MRNA | S 10b5-1 | 30.000 | $66,00 | $1.980.000 | 14.344 Langsung | -67,65% | Dilepas | 116,8% (harga per 2026-08-21) |
| 12 Mei 2020 | MRNA | S 10b5-1 | 30.000 | $66,00 | $1.980.000 | 14.344 Langsung | -67,65% | Dilepas | 116,8% (harga per 2026-08-21) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 10 Juni 2026 | LYEL | Option (right to buy) | Common Stock (9.250) | $13,22 | 9 Juni 2036 | 9.250 | Diakuisisi |
| 30 April 2025 | MRNA | Restricted Stock Units | Common Stock (16.233) | — | — | 16.233 | Diakuisisi |
| 30 April 2025 | MRNA | Restricted Stock Units | Common Stock (979) | — | — | 979 | Dilepas |
| 14 Juni 2024 | LYEL | Option (right to buy) | Common Stock (130.000) | $2,36 | 13 Juni 2034 | 130.000 | Diakuisisi |
| 6 Mei 2024 | MRNA | Restricted Stock Units | Common Stock (979) | — | — | 979 | Diakuisisi |
| 6 Mei 2024 | MRNA | Stock Option (Right to Buy) | Common Stock (5.668) | $122,13 | 6 Mei 2034 | 5.668 | Diakuisisi |
| 3 Mei 2024 | MRNA | Restricted Stock Units | Common Stock (732) | — | — | 732 | Dilepas |
| 8 Sep. 2023 | LYEL | Option (right to buy) [F1] | Common Stock (55.000) | $3,19 | 7 Sep. 2033 | 55.000 | Diakuisisi |
| 16 Juni 2023 | LYEL | Option (right to buy) | Common Stock (65.000) | $3,19 | 15 Juni 2033 | 65.000 | Diakuisisi |
| 3 Mei 2023 | MRNA | Restricted Stock Units | Common Stock (732) | $0,00 | — | 732 | Diakuisisi |
| 3 Mei 2023 | MRNA | Stock Option (Right to Buy) | Common Stock (4.601) | $130,14 | 3 Mei 2033 | 4.601 | Diakuisisi |
| 28 April 2023 | MRNA | Restricted Stock Units | Common Stock (670) | — | — | 670 | Dilepas |
| 8 Juni 2022 | LYEL | Option (right to buy) | Common Stock (65.000) | $5,31 | 7 Juni 2032 | 65.000 | Diakuisisi |
| 28 April 2022 | MRNA | Restricted Stock Units | Common Stock (670) | $0,00 | — | 670 | Diakuisisi |
| 28 April 2022 | MRNA | Stock Option (Right to Buy) | Common Stock (4.061) | $142,52 | — | 4.061 | Diakuisisi |
| 28 April 2022 | MRNA | Restricted Stock Units | Common Stock (703) | $0,00 | — | 703 | Dilepas |
| 28 April 2021 | MRNA | Restricted Stock Units | Common Stock (703) | $0,00 | — | 703 | Diakuisisi |
| 28 April 2021 | MRNA | Stock Option (Right to Buy) | Common Stock (4.081) | $178,68 | 28 April 2031 | 4.081 | Diakuisisi |
| 10 Maret 2021 | MRNA | Stock Option (Right to Buy) | Common Stock (1.139) | $129,75 | 10 Maret 2031 | 1.139 | Diakuisisi |
| 15 Juli 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (10.948) | $19,15 | 10 Agu 2026 | 10.948 | Dilepas |
| 15 Juli 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (8.376) | $19,15 | 10 Agu 2026 | 8.376 | Dilepas |
| 15 Juli 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (40.307) | $14,22 | 28 Feb. 2028 | 40.307 | Dilepas |
| 29 April 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (18.270) | $46,37 | 29 April 2030 | 18.270 | Diakuisisi |
| 27 Juni 2019 | MRNA | Stock Option (Right to Buy) | Common Stock (54.660) | $14,34 | 27 Juni 2029 | 54.660 | Diakuisisi |
| 11 Des. 2018 | MRNA | Series G Preferred Stock | Common Stock (13.679) | — | — | 13.679 | Dilepas |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 12 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 16 Juni 2021 | LYEL | Option (right to buy)→ Common Stock (400.000) | 400.000 | Langsung |
| 19 Des. 2018 | HQH | Shares of Beneficial Interest | 2.417 | Langsung |
| 19 Des. 2018 | HQL | Shares of Beneficial Interest | 2.787 | Langsung |
| 19 Des. 2018 | THQ | Shares of Beneficial Interest | 2.816 | Langsung |
| 19 Des. 2018 | THW | Shares of Beneficial Interest | 3.799 | Langsung |
| 7 Des. 2018 | MRNA | Common Stock | 30.665 | Langsung |
| 7 Des. 2018 | MRNA | Series G Preferred Stock→ Common Stock (13.679) | 13.679 | Langsung |
| 7 Des. 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (12.376) | 12.376 | Langsung |
| 7 Des. 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (10.948) | 10.948 | Langsung |
| 7 Des. 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (8.376) | 8.376 | Langsung |
| 7 Des. 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (42.201) | 42.201 | Langsung |
| 7 Des. 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (40.307) | 40.307 | Langsung |